drugset / Trial / NCT01608958

IV vs IM Oxytocin in the Third Stage of Labor for Prevention of Postpartum Hemorrhage

NCT01608958

RandomizedSingle-groupOpen-labelPrevention

Summary

The study will evaluate whether prophylactic oxytocin administered in the third stage of labor via IV infusion results in a lower mean blood loss compared to IM injection.

Timeline

Start
2012-05
Primary completion
2012-11
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 10 iu Intravenous

Indications

No indication recorded.